GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
Deep learning analysis of high-resolution pancreatic tissue images has identified subtle structural changes linked to beta cell dysfunction which offers novel insight into the development of type ...
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS®, 華領片®) has ...
Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis on PODD stock.
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...
Researchers used an ultra-thin electronic mesh to stimulate lab-grown pancreatic cells, improving maturation and insulin secretion.
A diagnosis of pancreatic cancer is devastating news. Though it makes up only about 3% of cancers in the United States, it’s one of the deadliest, and on track for a dark achievement: By 2030, it’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results